Tags : Global

J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

Shots: The initiation of the ENSEMBLE trial follows positive interim results of P-I/IIa study demonstrating the safety and immunogenicity of JNJ-78436735 following a single vaccination. The results have been submitted to medRxiv and expected to be published imminently The P-III ENSEMBLE study is designed to assess the safety & efficacy of a single vaccine dose […]Read More

ViewPoints Article: Covid-19 Impact On Global Telemedicine Market

The concept of telemedicine has evolved in recent years. As people are demanding easier ways to avail of medical treatment and diagnosis, there have been several advances in telemedicine. Telemedicine is a method that involves providing clinical services through a distance. Through telemedicine, the user doesn’t necessarily have to be present at the hospital or […]Read More

AstraZeneca Signs an Agreement with Daichii Sankyo to Develop and

Shots: Daichii Sankyo to receive $1B as upfront of which $350M is due upon execution, $325M after 12mos. and $325M after 24 mos., ~$5B as contingent payment including $1B as regulatory milestones, and $4B as commercial milestones, making a total deal value up to ~6B The companies will jointly develop and commercialize DS-1062 globally and […]Read More

Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic

Shots: Sorrento enters into letter of intent to acquire SmartPharm and develops pipeline of gene-encoded therapeutic Ab, initiating with Sorrento’s STI-1499 or COVI-GUARD, currently preclinical studies with an IND submission targeted for Aug’2020. The transaction is expected to be close in Aug’2020. The integration of Sorrento’s G-MAB Ab library and SmartPharm’s GET platform is expected […]Read More

Pfizer and BioNTech Provide Updates on its Collaboration for Global

Shots: BioNTech to receive $185M up front, including $72M cash & $113M equity investment, up to $563M as milestone making a total deal value $748M. The companies will equally share the development cost while Pfizer will fund 100% of development cost at the initial level and BioNTech will repay Pfizer its 50% share during the […]Read More

Medopad Provides its Remote Patient Monitoring Platform to Support Global

Shots: Medopod’s RPM platform will be available for NHS Trusts across the UK as well as global healthcare providers that allow doctors to track patient’s data, symptom progression and flag patients with worsening symptoms, both inside and outside of clinical settings Patients will use the app to share their personal data such as temperature, respiration […]Read More

­WHO to Accelerate Global Research and Innovation Against Corona Virus

Shots: WHO convoke global research and innovation forum to be held on Feb 11-12, 2020 in Geneva for mobilization of international action in response to the coronavirus (2019-nCoV) and is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness The forum will involve scientist, public health agencies, ministries of health and research […]Read More

Everyday Health Group to Acquire Johnson and Johnson’s BabyCenter a

Shots: Everyday Health acquires BabyCenter combining its What to Expect digital pregnancy and parenting platform, with the focus of supporting parents through the journey of pregnancy and early parenting plus combined expertise for engaging digital experiences of parenthood What to Expect is Everyday Health’s first rated digital pregnancy app in the Apple Store, awarded under […]Read More